Comments due: 
16 Mar 2020

According to the World Psoriasis Day consortium, 125 million people worldwide have psoriasis. Nearly 60 percent of people with psoriasis reported their disease to be a large problem in everyday life.

CDISC invites you to provide comments on Version 1.0 of the Therapeutic Area User Guide (TAUG) for Psoriasis during the open Public Review. TAUG for Psoriasis v1.0 is being developed under the CDISC Standards Development Process and describes the most common biomedical concepts relevant to Psoriasis and the necessary metadata to represent such consistently with CDISC standards CDASHSDTM and ADaM.
 
 
You will need to log in or register for the CDISC Wiki to provide comments.  
  • Register for the Wiki. If you already have an account on Wiki or JIRA, our issue-tracking system, simply log in to your account; Wiki and JIRA use the same login credentials. CDISC Wiki is a different login from www.cdisc.org.
Public review is a key quality step in our Standards Development Process. We rely on your input to ensure neutral, consensus-based standards are developed and adopted by a diverse global community interested in improving clinical research. Thank you for contributing your time and expertise.
 
Join us for the Public Review Webinar 23 Jan 2020 10:00 AM - 11:30 AM Central US Standard Time. We will run through highlights of the guide as well as known Issues, which need your expertise. Come with your questions.